Advertisement
Advertisement

CRL

CRL logo

Charles River Laboratories International, Inc.

233.60
USD
Sponsored
+9.64
+4.30%
Jul 09, 15:59 UTC -4
Closed
exchange

After-Market

234.28

+0.68
+0.29%

CRL Earnings Reports

Positive Surprise Ratio

CRL beat 41 of 41 last estimates.

100%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$983.43M
/
$2.75
Implied change from Q1 26 (Revenue/ EPS)
-1.24%
/
+33.50%
Implied change from Q2 25 (Revenue/ EPS)
-4.72%
/
-11.86%

Charles River Laboratories International, Inc. earnings per share and revenue

On May 07, 2026, CRL reported earnings of 2.06 USD per share (EPS) for Q1 26, beating the estimate of 1.96 USD, resulting in a 4.98% surprise. Revenue reached 995.83 million, compared to an expected 987.26 million, with a 0.87% difference. The market reacted with a -0.03% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of 2.75 USD, with revenue projected to reach 983.43 million USD, implying an increase of 33.50% EPS, and decrease of -1.24% in Revenue from the last quarter.
FAQ
For Q1 2026, Charles River Laboratories International, Inc. reported EPS of $2.06, beating estimates by 4.98%, and revenue of $995.83M, 0.87% above expectations.
The stock price moved down -0.03%, changed from $181.73 before the earnings release to $181.68 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 13 analysts, Charles River Laboratories International, Inc. is expected to report EPS of $2.75 and revenue of $983.43M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement